Clinical Trials
3 trialsNCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
NCT01883518 2019-11-20
ADCVCTAST
N.N. Petrov National Medical Research Center of Oncology
Phase 1/2 Unknown
NCT02587169 2015-10-27
GEIS-27
Broto, Javier MartÃn, M.D.
Phase 1/2 Unknown